Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002487614 | SCV002780587 | uncertain significance | Pyruvate dehydrogenase E1-beta deficiency | 2022-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027328 | SCV005003729 | uncertain significance | Inborn genetic diseases | 2023-12-20 | criteria provided, single submitter | clinical testing | The c.10G>A (p.V4M) alteration is located in exon 1 (coding exon 1) of the PDHB gene. This alteration results from a G to A substitution at nucleotide position 10, causing the valine (V) at amino acid position 4 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Clinical Molecular Genetics Laboratory, |
RCV000781979 | SCV000920434 | uncertain significance | Seizure | 2017-09-01 | no assertion criteria provided | clinical testing |